FDA is launching real-time monitoring of drug trials, with AstraZeneca and Amgen as first test cases
Culture Index
Score Breakdown
Relevance
9/25
Freshness
25/25
Authority
18/20
Brand Signal
3/15
Depth
2/15
5-Axis Cultural Radar
The agency says 45% of drug development time is currently "dead time" — real-time data access could cut months or years from the process
